These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1438973)
1. Neuropeptide Y 16-36 inhibits mucociliary activity but does not affect blood flow in the rabbit maxillary sinus in vivo. Cervin A Regul Pept; 1992 Jun; 39(2-3):237-46. PubMed ID: 1438973 [TBL] [Abstract][Full Text] [Related]
2. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y. Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710 [TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor. Haynes JM; Hill SJ; Selbie LA Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306 [TBL] [Abstract][Full Text] [Related]
4. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein. Palea S; Corsi M; Rimland JM; Trist DG Br J Pharmacol; 1995 May; 115(1):3-10. PubMed ID: 7647980 [TBL] [Abstract][Full Text] [Related]
5. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem. Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753 [TBL] [Abstract][Full Text] [Related]
6. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors. Widdowson PS; Buckingham R; Williams G Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897 [TBL] [Abstract][Full Text] [Related]
7. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine. Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798 [TBL] [Abstract][Full Text] [Related]
8. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor. Lacroix JS; Ulman LG; Potter EK Br J Pharmacol; 1994 Oct; 113(2):479-84. PubMed ID: 7834199 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226. Lundberg JM; Modin A Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732 [TBL] [Abstract][Full Text] [Related]
10. The effect of neuropeptide Y on mucociliary activity in the rabbit maxillary sinus. Cervin A; Lindberg S; Mercke U Acta Otolaryngol; 1991; 111(5):960-6. PubMed ID: 1684689 [TBL] [Abstract][Full Text] [Related]
11. Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub-types on arterioles of the guinea-pig small intestine and the rat brain. Xia J; Neild TO; Kotecha N Br J Pharmacol; 1992 Nov; 107(3):771-6. PubMed ID: 1472974 [TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y in the rabbit maxillary sinus modulates cholinergic acceleration of mucociliary activity. Cervin A; Lindberg S; Mercke U; Uddman R Acta Otolaryngol; 1992 Sep; 112(5):872-81. PubMed ID: 1456044 [TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor. Monnet FP; Fournier A; Debonnel G; de Montigny C J Pharmacol Exp Ther; 1992 Dec; 263(3):1212-8. PubMed ID: 1469629 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea. Grundemar L Regul Pept; 1997 Aug; 71(2):97-101. PubMed ID: 9416991 [TBL] [Abstract][Full Text] [Related]
15. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system. Larsen PJ; Sheikh SP; Jakobsen CR; Schwartz TW; Mikkelsen JD Eur J Neurosci; 1993 Dec; 5(12):1622-37. PubMed ID: 8124516 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle. Misra S; Mahavadi S; Grider JR; Murthy KS Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728 [TBL] [Abstract][Full Text] [Related]
17. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors. Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079 [TBL] [Abstract][Full Text] [Related]
18. In vitro steroidogenic effects of neuropeptide Y (NPY1-36), Y1 and Y2 receptor agonists (Leu31-Pro34 NPY, NPY18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa. Bernet F; Maubert E; Bernard J; Montel V; Dupouy JP Regul Pept; 1994 Aug; 52(3):187-93. PubMed ID: 7800851 [TBL] [Abstract][Full Text] [Related]
19. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats. Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621 [TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effects of neuropeptide Y and related peptides in mice. Broqua P; Wettstein JG; Rocher MN; Gauthier-Martin B; Riviere PJ; Junien JL; Dahl SG Brain Res; 1996 Jun; 724(1):25-32. PubMed ID: 8816252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]